M&As and strategic partnerships to drive development of nanopharmaceuticals

March 20 2020

Nanopharmaceuticals have many physical and biological advantages compared to conventional medicines such as enhanced efficacy, reduced toxicity, improved solubility and stability, targeted tissue selectivity and extended-release.